Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.

Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol. 2000 Jan; 23(1):39-46.

View in: PubMed

subject areas

Adult
Aged
Anticholesteremic Agents
Cholesterol, HDL
Cholesterol, LDL
Cholesterol, VLDL
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Hypercholesterolemia
Lipids
Male
Middle Aged
Simvastatin
Treatment Outcome
Triglycerides

authors with profiles

Michael H. Davidson